This inventor holds 1 USPTO granted patent. Top assignee: Celgene Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthew Patton: Innovator in Pharmaceutical Research
Introduction
Matthew Patton is a notable inventor based in Cambridge, MA. He has made significant contributions to the field of pharmaceutical research, particularly in the development of MK2 inhibitors. His work has the potential to impact various therapeutic areas.
Latest Patents
Matthew holds a patent for "MK2 INHIBITORS AND USES THEREOF." This patent represents his innovative approach to addressing specific medical challenges through targeted inhibition.
Career Highlights
Matthew is currently employed at Celgene Corporation, a leading biopharmaceutical company. His role involves extensive research and development, focusing on creating effective treatments for patients.
Collaborations
Matthew has collaborated with talented coworkers, including Xirui Hu and Lixin Qiao. Together, they contribute to advancing research and innovation within their field.
Conclusion
Matthew Patton exemplifies the spirit of innovation in the pharmaceutical industry. His work on MK2 inhibitors showcases his commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile